" /> Tumor lysis syndrome - CISMeF





Preferred Label : Tumor lysis syndrome;

Inclusion CIM-10 : Tumor lysis syndrome following antineoplastic drug chemotherapy; Tumor lysis syndrome (spontaneous);

CMA : 2;

Source : OMS;

Date de début : 01/01/2010;

Details


You can consult :


Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.